Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Immunol. 2018 Feb 12;200(7):2313–2326. doi: 10.4049/jimmunol.1601765

Figure 3.

Figure 3

Cdc42 deficiency increases disease severity of colitis. (A) Body weight loss of Cdc42+/+LckCre and Cdc42fl/flLckCre mice treated with DSS in drinking water or normal water only. The data are expressed as percentage of initial body weight. (B) Representative flow cytogram of IL-17- and IFN-γ-producing CD4+ cells in the lamina propria of DSS-treated Cdc42+/+LckCre and Cdc42fl/flLckCre mice. Numbers in dot plots indicate percentages of IL-17- and IFN-γ-producing CD4+ cells (left). Average percentages of IL-17- and IFN-γ-producing CD4+ cells are shown in bar graph (right). (C) Body weight loss of RAG1−/− mice transferred with naïve CD4+ T cells from Cdc42+/+LckCre and Cdc42fl/flLckCre mice. (D) Average percentages of IL-17+, IFN-γ+ and IL-17+IFNγ+ cells in the spleen, mLN and lamina propria of RAG1−/− mice in (C). n = 5. Error bars indicate SD. *p < 0.05, **p < 0.01.